E

Elanco Animal Health
D

ELAN

12.670
USD
-0.01
(-0.04%)
مغلق
حجم التداول
163,286
الربح لكل سهم
1
العائد الربحي
-
P/E
17
حجم السوق
6,292,511,206
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
A
AUPH
-0.19500
(-2.36%)
8.07000 USD
BIIB
BIIB
-0.465
(-0.37%)
125.825 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
CAH
CAH
0.250
(0.16%)
152.750 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
I
INO
-0.06000
(-2.98%)
1.95500 USD
المزيد
الأخبار المقالات

العنوان: Elanco Animal Health

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.